Skeletal Muscle Transcriptional Networks Linked to Type I Myofiber Grouping in Parkinson's Disease.
Parkinson's disease (PD) is a common neurodegenerative disorder impacting cognition, movement, and quality of life in >10 million individuals worldwide. We recently characterized and quantified a skeletal muscle pathology in PD represented by exaggerated type I myofiber grouping presumed to result from denervation-reinnervation processes. Our previous findings indicated impaired neuromuscular junction integrity may be involved in type I grouping, which is associated with excessive motor unit activation during weight-bearing tasks. In this study, we performed transcriptional profiling to test the hypothesis that type I grouping severity would link to distinct gene expression networks. We generated transcriptome-wide poly-A RNA-Seq data from skeletal muscle of individuals with PD [n=12, (9men, 3women), 67±2yr], age- and sex-matched older adults (OA) (n=12, 68±2yr), and sex-matched young adults (YA) (n=12, 30±1yr). Differentially expressed genes were evaluated across cohorts. Weighted Gene Correlation Network Analysis (WGCNA) was performed to identify gene networks most correlated with indicators of abnormal type I grouping. Among co-expression networks mapping to phenotypes pathologically increased in PD muscle, one network was highly significantly correlated to type I myofiber group size and another to percentage of type I myofibers found in groups. Annotation of co-expressed networks revealed that type I grouping is associated with altered expression of genes involved in neural development, post-synaptic signaling, cell cycle regulation and cell survival, protein and energy metabolism, inflammation/immunity, and post-transcriptional regulation (microRNAs). These transcriptomic findings suggest skeletal muscle may play an active role in signaling to promote myofiber survival, reinnervation, and remodeling, perhaps to an extreme in PD.